Cresco Pharma

Melodiol Global Health, formerly known as Cresco Pharma, is an Australian-based company specializing in the development and commercialization of pharmaceutical-grade cannabis and hemp-derived therapeutic products. The company operates across a diverse portfolio including medicinal cannabis, hemp-based nutraceuticals, and psychedelic medicine through its subsidiary Halucenex Life Sciences. Melodiol focuses on addressing unmet medical needs in areas such as chronic pain, anxiety, and PTSD using standardized delivery systems. With a global footprint spanning Australia, Europe, and North America, the company integrates research and development with a robust distribution network for both human and animal health products.